$21.38
0.110.52%
In chiusura: -
$21.44
0.060.28%
After hour: Oct 31, 4:35 PM EDT
Comments
Loading...
Guidance e previsioni
Pacira BioSciences fornisce indicazioni su EPS e ricavi futuri, offrendo agli investitori informazioni su quanto la società prevede di guadagnare nei prossimi periodi.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
08/05/2025 | PCRX | Pacira BioSciences | FY | 2025 | — | — | — | $730.00M | $750.00M | $743.16M | |
05/08/2025 | PCRX | Pacira BioSciences | FY | 2025 | — | — | — | $725.00M | $765.00M | $752.89M | |
02/27/2025 | PCRX | Pacira BioSciences | FY | 2025 | — | — | — | $725.00M | $765.00M | $747.55M | |
01/10/2025 | PCRX | Pacira BioSciences | FY | 2024 | — | — | — | $701.00M | $701.00M | $695.18M | |
11/06/2024 | PCRX | Pacira BioSciences | FY | 2024 | — | — | — | $680.00M | $705.00M | — | |
07/30/2024 | PCRX | Pacira BioSciences | FY | 2024 | — | — | — | $680.00M | $705.00M | $694.66M | |
05/07/2024 | PCRX | Pacira BioSciences | FY | 2024 | — | — | — | $680.00M | $705.00M | $691.61M | |
02/29/2024 | PCRX | Pacira BioSciences | FY | 2024 | — | — | — | $680.00M | $705.00M | $722.45M | |
01/04/2024 | PCRX | Pacira BioSciences | Q4 | 2023 | — | — | — | $181.20M | $181.20M | $179.91M | |
01/04/2024 | PCRX | Pacira BioSciences | FY | 2023 | — | — | — | $675.00M | $675.00M | $677.30M | |
01/05/2023 | PCRX | Pacira BioSciences | FY | 2022 | $2.50 | — | $2.77 | $666.80M | $666.80M | $671.30M | |
10/13/2022 | PCRX | Pacira BioSciences | Q3 | 2022 | — | — | — | $167.50M | $167.50M | $172.72M | |
07/14/2022 | PCRX | Pacira BioSciences | Q2 | 2022 | — | — | — | $169.40M | $169.40M | $174.91M | |
04/12/2022 | PCRX | Pacira BioSciences | Q1 | 2022 | — | — | — | $157.40M | $158.40M | $162.85M | |
01/06/2022 | PCRX | Pacira BioSciences | FY | 2021 | — | — | — | $540.70M | $541.70M | $534.70M | |
07/13/2021 | PCRX | Pacira BioSciences | Q2 | 2021 | — | — | — | $135.60M | $135.60M | $128.01M |
FAQ
Qual è la guidance più recente per Pacira BioSciences (PCRX)?
Negli ultimi mesi non sono state riportate guidance specifiche sulle vendite o sugli utili di Pacira BioSciences.
Sfoglia guidance e previsioni su tutte le azioni.